Billerud korsnäs Full-Year Report 2023

Highlights

• Net sales decreased by 20% to SEK 9,566 million (11,971)
• Adjusted EBITDA* SEK 774 million (2,092)
• Adjusted EBITDA margin 8% (17)
• Operating loss SEK 191 million (profit: 1,353) including items affecting comparability of SEK -244 million (-52)
• Net loss SEK 330 million (profit: 940)
• Earnings per share SEK -1.33 (3.79)
• Excellent cash delivery through working capital focus
• Negative profit impact from revaluation of biological assets in the associated company BSO
• The Board of Directors proposes a dividend of SEK 2.00 per share (7.50)